申请人:Dobler Markus Rolf
公开号:US20080255149A1
公开(公告)日:2008-10-16
The invention relates to the use of carboxyamine compounds and salts thereof in the treatment of HDAC dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases.
本发明涉及使用羧酰胺化合物及其盐来治疗依赖HDAC的疾病,并用于制造治疗该类疾病的药物制剂。